PeptiDream (TSE:4587) Beneish M-Score: -1.23 (As of Jun. 25, 2026)


TSE:4587 PeptiDream Inc TSE:4587
66 GF Score
Price 円987.50
GF Value 円1,579.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Beneish M-Score?

PeptiDream TSE:4587 +1.50% 66 Beneish M-Score is -1.23 as of Jun. 25, 2026. GuruFocus rates TSE:4587 with a GF Score™ of 66/100 and a GF Value™ of 円1,579.77 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 831 Biotechnology companies, PeptiDream ranks worse than 75.81% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.23 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for PeptiDream's Beneish M-Score or its related term are showing as below:

TSE:4587' s Beneish M-Score Range Over the Past 10 Years
Min: -4.56   Med: -1.36   Max: 53.06
Current: -1.23

During the past 13 years, the highest Beneish M-Score of PeptiDream was 53.06. The lowest was -4.56. And the median was -1.36.


PeptiDream Beneish M-Score Historical Data

* Premium members only.

The historical data trend for PeptiDream's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Beneish M-Score Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.47 4.44 -3.60 -2.90 -0.34

PeptiDream Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.31 -4.56 -0.65 -0.34 -1.23

TSE:4587 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, PeptiDream's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PeptiDream's Beneish M-Score falls into.


TSE:4587
66GF Score
PeptiDream Inc TSE:4587
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PeptiDream for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.5693+0.528 * 1.7419+0.404 * 1.1265+0.892 * 0.4081+0.115 * 1.0944
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.0421+4.679 * 0.011069-0.327 * 0.9775
=-1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was 円4,935 Mil.
Revenue was 4764.959 + 5663.852 + 4313.594 + 4310.542 = 円19,053 Mil.
Gross Profit was 2027.809 + 2687.04 + 1669.731 + 1696.96 = 円8,082 Mil.
Total Current Assets was 円36,722 Mil.
Total Assets was 円74,696 Mil.
Property, Plant and Equipment(Net PPE) was 円18,821 Mil.
Depreciation, Depletion and Amortization(DDA) was 円2,118 Mil.
Selling, General, & Admin. Expense(SGA) was 円7,561 Mil.
Total Current Liabilities was 円9,044 Mil.
Long-Term Debt & Capital Lease Obligation was 円13,730 Mil.
Net Income was -854.895 + -531.864 + -1094.85 + -1089.111 = 円-3,571 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = 円0 Mil.
Cash Flow from Operations was -945.684 + -732.486 + -1591.822 + -1127.535 = 円-4,398 Mil.
Total Receivables was 円4,707 Mil.
Revenue was 4233.246 + 5072.189 + 5470.709 + 31908.459 = 円46,685 Mil.
Gross Profit was 1468.619 + 1964.558 + 2578.405 + 28482.186 = 円34,494 Mil.
Total Current Assets was 円44,947 Mil.
Total Assets was 円80,735 Mil.
Property, Plant and Equipment(Net PPE) was 円17,411 Mil.
Depreciation, Depletion and Amortization(DDA) was 円2,168 Mil.
Selling, General, & Admin. Expense(SGA) was 円9,072 Mil.
Total Current Liabilities was 円8,788 Mil.
Long-Term Debt & Capital Lease Obligation was 円16,392 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4935.266 / 19052.947) / (4706.632 / 46684.603)
=0.259029 / 0.100818
=2.5693

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(34493.768 / 46684.603) / (8081.54 / 19052.947)
=0.738868 / 0.424162
=1.7419

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (36722.373 + 18821.28) / 74696.353) / (1 - (44947.005 + 17410.929) / 80734.989)
=0.256407 / 0.227622
=1.1265

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=19052.947 / 46684.603
=0.4081

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2167.574 / (2167.574 + 17410.929)) / (2118.197 / (2118.197 + 18821.28))
=0.110712 / 0.101158
=1.0944

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7560.579 / 19052.947) / (9071.839 / 46684.603)
=0.396819 / 0.194322
=2.0421

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((13729.898 + 9043.764) / 74696.353) / ((16392.114 + 8788.22) / 80734.989)
=0.304883 / 0.311889
=0.9775

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-3570.72 - 0 - -4397.527) / 74696.353
=0.011069

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PeptiDream has a M-score of -1.23 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.23 mean?
PeptiDream (TSE:4587) has a Beneish M-Score of -1.23 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PeptiDream and its competitors. According to the industry distribution chart, PeptiDream ranks #630 out of 831 companies in the Biotechnology industry, placing it in the top 75.8%.
Is PeptiDream's Beneish M-Score too high?
PeptiDream's current Beneish M-Score is -1.23. Based on the distribution chart, PeptiDream ranks #630 out of 831 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PeptiDream has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PeptiDream ranks #630 out of 831 companies for Beneish M-Score. This places PeptiDream in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on PeptiDream and its competitors. PeptiDream's current Beneish M-Score is -1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (TSE:4587) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,579.77, compared to a current price of 円987.50 — trading 37.5% below its estimated fair value. The current Beneish M-Score is -1.23. PeptiDream's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For PeptiDream (TSE:4587), the current Beneish M-Score is -1.23 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (TSE:4587) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of 円987.50 is trading 37.5% below its estimated GF Value™ of 円1,579.77. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for TSE:4587:

  • Beneish M-Score: -1.23
  • GF Value™: 円1,579.77 vs. price of 円987.50 (37.5% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the TSE:4587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PeptiDream Business Description

Other Exchanges PPTDF:USA
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
66GF Score

Get the complete analysis for TSE:4587

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円987.50
Price
円1,579.77
GF Value